Web Results

Cipher Pharmaceuticals

www.cipherpharma.com/

Cipher Pharmaceuticals is a growing specialty company with a focus on dermatology. Our goal is to develop and acquire best-in-class skin care solutions.

Cipher Pharmaceuticals announces U.S. commercial entry through ...

www.prnewswire.com/news-releases/cipher-pharmaceuticals-announces-us-commercial-entry-through-acquisition-of-innocutis-499547201.html

Apr 13, 2015 ... ... that it has acquired INNOCUTIS Holdings LLC ("INNOCUTIS"), a privately held specialty dermatology company, for US$45.5 million in cash.

Innocutis Holdings LLC - Company Profile - BioCentury

www.biocentury.com/companies/innocutis_holdings_llc

Apr 2, 2012 ... BioAlliance Pharma S.A. (Euronext:BIO), Paris, France Innocutis Holdings LLC, Charleston, S.C. Business: Infectious BioAlliance granted ...

Innocutis Holdings LLC Licenses Sitavig from BioAlliance Pharma

sitavig.com/innocutis-holdings-llc-licenses-sitavig-bioalliance-pharma/

Mar 19, 2014 ... Innocutis Holdings LLC is pleased to announce the licensing of Sitavig® ( ACYCLOVIR) 50mg Buccal Tablets, from BioAlliance Pharma for ...

DailyMed - UMECTA PD UREA- urea suspension

dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=514d9b31-f9ef-4139-9eca-5c6782a0d9c3

More Info For This Drug. View Label Archives; RxNorm; Get Label RSS Feed. NDC Code(s): 68712-018-01, 68712-018-02; Packager: Innocutis Holdings LLC.

GLYCOBIOSCIENCES, INC. v. INNOCUTIS HOLDINGS, LLC et al

search.rpxcorp.com/lit/dcdce-157041-glycobiosciences-v-innocutis-holdings

GLYCOBIOSCIENCES, INC. v. INNOCUTIS HOLDINGS, LLC et al. 1:12-cv- 01901; Filed: 11/25/2012; Case Updated Daily; Latest Docket Entry: 09/15/2016 ...

DailyMed - UMECTA UREA- urea film

dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd7b3fe5-8ba6-4808-8ead-1b20a87a2ed2

NDC Code(s): 68712-010-01, 68712-010-03, 68712-010-04; Packager: Innocutis Holdings LLC. Category: HUMAN PRESCRIPTION DRUG LABEL; DEA ...

DailyMed - UMECTA MOUSSE UREA - urea foam aerosol, foam

dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=53f903a2-2b5c-4584-8e91-2c9f41b883ea

NDC Code(s): 68712-020-01; Packager: Innocutis Holdings LLC. Category: HUMAN PRESCRIPTION DRUG LABEL; DEA Schedule: None; Marketing Status:  ...

Cipher Pharma maps out its path to success - The Globe and Mail

www.theglobeandmail.com/globe-investor/investment-ideas/cipher-pharma-maps-out-its-path-to-success/article24053442/

Apr 21, 2015 ... ... company Innocutis Holdings LLC for $45.5-million (U.S.) in cash, its ... Innocutis gives Cipher critical infrastructure to sell its products in the ...

Sitavig (Innocutis Holdings, LLC): FDA Package Insert

medlibrary.org/lib/rx/meds/sitavig-1/

Aug 21, 2014 ... Innocutis Holdings, LLC: SITAVIG is indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults (1).

More Info

Cipher Pharmaceuticals acquires INNOCUTIS Holdings ... - Onxeo

www.onxeo.com

Apr 13, 2015 ... oncology drugs, today announced Cipher Pharmaceuticals' (NASDAQ: CPHR) acquisition of INNOCUTIS. Holdings LLC, the licensee of ...

innocutis | CrunchBase

www.crunchbase.com

Innocutis is a pharmaceutical and medical device company developing therapeutic ... Founded: 2005; Aliases: Innocutis Holdings, LLC; Contact: 843- 965-8333 ...

Charles F. Jenkins | LinkedIn

www.linkedin.com

Cipher Pharmaceuticals Inc. Previous. Innocutis Holdings, LLC,; Innocutis Medical, LLC,; Medicis. Education. University of South Carolina-Columbia. Websites.